Pharmaceutical Drug Supply – Sodium Nitroprusside, USP

The contract requires the supply of 25 vials of FDA-approved Sodium Nitroprusside, USP, a sterile intravenous medication used for the rapid control of acute hypertension, with strict adherence to USP standards and hazardous materials handling protocols. Each vial must be fully traceable with accurate NDC codes and packaged to ensure integrity during transport and storage, complying with all federal regulations for controlled pharmaceutical substances. The product must meet the highest quality and safety benchmarks established for clinical use in military and federal healthcare settings. This is a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA, with performance located at Fort Stewart, Georgia, 31314-5185. The solicitation was posted on July 15, 2026, and responses are due by July 21, 2026. The NAICS code 325412 indicates the business category as pharmaceutical and medicine manufacturing, ensuring only qualified manufacturers or distributors with appropriate licensing and experience in sterile injectables are eligible to respond. All deliveries must align with the Department of Defense’s supply chain requirements for reliability, documentation, and regulatory compliance.